Skip to main content

Table 4 Adverse Events

From: Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study

Adverse Event

FP (n = 64)

F (n = 65)

p-value

All Gr.

Gr. 3–4

All Gr.

Gr. 3–4

No. (%)

No. (%)

No. (%)

No. (%)

All Gr.

Gr. 3–4

Leukocytopenia

40 (63)

11 (17)

23 (35)

5 (8)

< 0.01

0.10

Neutropenia

39 (61)

23 (36)

17 (26)

7 (11)

< 0.01

< 0.01

Anemia

51 (80)

12 (19)

37 (57)

15 (23)

< 0.01

0.55

Thrombocytopenia

37 (58)

3 (5)

9 (14)

0 (0)

< 0.01

0.08

Febrile neutropenia

3 (5)

3 (5)

3 (5)

3 (5)

0.98

0.98

Anorexia

42 (66)

10 (16)

37 (57)

17 (26)

0.31

0.14

Nausea

40 (63)

3 (5)

34 (52)

1 (2)

0.24

0.30

Vomiting

18 (28)

1 (2)

23 (35)

2 (3)

0.38

0.57

Diarrhea

16 (25)

3 (5)

18 (28)

1 (2)

0.73

0.30

Stomatitis

14 (22)

1 (2)

7 (11)

0 (0)

0.09

0.31

Fatigue

27 (42)

2 (3)

27 (42)

3 (5)

0.94

0.66

Sensory neuropathy

24 (38)

1 (2)

0 (0)

0 (0)

< 0.01

0.31